Silencing SIRT2, a sirtuin enzyme, reduces malignancy in deadly breast cancer subtype

Silencing SIRT2, a member of the sirtuin family of enzymes, reduces the invasiveness of basal-like breast cancer cells in culture and inhibits tumor growth in mice, according to new research.